SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C/A - Offering Statement: [Amend]
SEC Accession No. 0001669191-21-000159
Filing Date
2021-02-16
Accepted
2021-02-16 14:45:03
Documents
9

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 10125
2 OFFERING STATEMENT PDF offeringstatement.pdf EX-99 138049
3 OFFERING PAGE JPG offeringpage.jpg GRAPHIC 1319985
4 CPA REVIEW REPORT reviewletter.pdf EX-99 3764994
5 CERTIFICATE OF FORMATION certificateofformation.pdf EX-99 1659190
6 OPERATING AGREEMENT operatingagreement.pdf EX-99 890059
7 PITCH DECK pitchdeck.pdf EX-99 2676400
8 ADDITIONAL INFORMATION otherfinancial.pdf EX-99 140687
9 IMAGE ATTACHMENTS HTML imageattachments.htm EX-99 244
  Complete submission text file 0001669191-21-000159.txt   14593456
Mailing Address 20 CORPORATE PARK DRIVE UNIT 170/180 PEMBROKE MA 02359
Business Address 20 CORPORATE PARK DRIVE, UNIT 170/180 PEMBROKE MA 02359 2026319143
C-REVEAL THERAPEUTICS LLC (Filer) CIK: 0001834759 (see all company filings)

IRS No.: 842683676 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C/A | Act: 33 | File No.: 020-27353 | Film No.: 21636540